Current research is encouraging, but there are still important questions that only larger human studies conducted over longer periods will be able to answer
BPC 157 and Standard Angiogenic Growth Factors Key Findings: BPC-157, when compared to standard peptidergic angiogenic growth factors (EGF, FGF, VEGF), has been effective in all models of acute/chronic injury of the gastrointestinal tract, whether administered intraperitoneally, per-orally, or locally
This treatment usually mixes methionine, inositol, choline, and vitamin B12
Tendon and Ligament Models BPC-157 has been investigated in connective tissue research models examining fibroblast migration, cytoskeletal signaling, and extracellular matrix organization during tendon repair
Well check for signs of nutritional deficiencies , review your history, and map out a plan that works